Congress Presentation
OPINION Trial: 1-Year Outcomes
1 September 2025
Congress Presentation
The TOP-CABG trial
1 September 2025
Congress Presentation
TACSI: Dual or single antiplatelet therapy after CABG in patients with acute coronary syndrome
1 September 2025
Congress Presentation
NEWTON-CABG CardioLink-5: Evolocumab and Saphenous Vein Graft Patency
1 September 2025
Congress Presentation
IMPACT-BP Implementation of a Combination Intervention for Sustainable Blood Pressure Control in rural South Africa
1 September 2025
Congress Presentation
Project MHYH: One-Year Results
1 September 2025
Congress Presentation
HELP-MI SWEDEHEART – Randomised H. pylori screening after MI
1 September 2025
Congress Presentation
PARACHUTE-HF: Randomized trial comparing sacubitril/valsartan with enalapril in patients with HFrEF caused by chronic Chagas cardiomyopathy
1 September 2025
Congress Presentation
DAPT-SHOCK-AMI trial, Cangrelor in cardiogenic shock.
31 August 2025
Congress Presentation
TAILORED-CHIP: Tailored Antiplatelet Therapy for Complex High-Risk PCI
31 August 2025
Congress Presentation
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
31 August 2025
Congress Presentation
OPTION-STEMI: Timing of complete revascularization during index hospitalization in patients with STEMI and multivessel disease
31 August 2025
Congress Presentation
The AQUATIC trial
31 August 2025
Congress Presentation
The PULSE randomized controlled trial
31 August 2025
Congress Presentation
SWEDEPAD 1 and 2: Impact of drug-coated devices in patients with peripheral arterial disease
31 August 2025
Congress Presentation
HI-PRO: Apixaban for Extended Treatment of Provoked Venous Thromboembolism
30 August 2025
Congress Presentation
ABC-AF study - a randomised controlled study of personalised treatment to reduce stroke or death in atrial fibrillation
30 August 2025
Congress Presentation
PREVENT-MINS trial:Ivabradine for Prevention of Myocardial Injury After Noncardiac Surgery
30 August 2025
Congress Presentation
DANCAVAS 2: Screening and intervention to prevent cardiovascular disease and death
30 August 2025
Congress Presentation
VICTORION-Difference study: Inclisiran-based strategy vs standard of care
30 August 2025
Congress Presentation
Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: the Essence-TIMI 73b trial
30 August 2025
Congress Presentation
KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk
30 August 2025
Congress Presentation
BaxHTN – Efficacy and safety of the aldosterone synthase inhibitor baxdrostat in patients with uncontrolled or resistant hypertension
30 August 2025
Congress Presentation
REFINE ICD: Efficacy of ICD therapy in higher risk post-MI patients with better-preserved LV function
30 August 2025
